• Publications
  • Influence
Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution
Purpose: Unequivocal pathologic markers for the prognosis of pancreatic endocrine tumors are often lacking. Suggestions for prognostic guidance include the WHO classification. Recently, aExpand
  • 302
  • 18
Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors
Purpose: A retrospective analysis of the toxicity and efficacy of temozolomide in advanced neuroendocrine tumors. Experimental Design: Thirty-six patients with advanced stages of neuroendocrine tumorExpand
  • 381
  • 13
Co‐expression of ghrelin and its receptor in pancreatic endocrine tumours
Objective  Expression of ghrelin has been reported in pancreatic endocrine tumours, but data on ghrelin receptor protein expression are lacking. The aim of this study was to examine the ghrelinExpand
  • 45
  • 1
Gastrointestinal stromal tumors express the orexigen ghrelin.
Expression of the neuroendocrine marker synaptic vesicle protein 2 (SV2) has been reported in a few cases of gastrointestinal stromal tumors (GISTs). The goal of the present study was to assess theExpand
  • 23
  • 1
Prognostic Relevance of Survivin in Pancreatic Endocrine Tumors
BackgroundBetter prognostic markers are needed for pancreatic endocrine tumors. Survivin is an apoptosis inhibitor that is suggested to have a negative prognostic impact in several tumor types.Expand
  • 16
  • 1
Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
BACKGROUND Data on downstream effects of MEN1 gene inactivation is scarce. In an effort to identify genes regulated by MEN1, we designed a silencing experiment in a human endocrine pancreatic tumorExpand
  • 13
Islet cell tumours.
  • Sara Ekeblad
  • Medicine
  • Advances in experimental medicine and biology
  • 2010
Pancreatic endocrine tumours can cause hormonal symptoms by over-secretion of hormones. They are less aggressive than exocrine pancreatic cancer, but carry a variable prognosis. The tumours areExpand
  • 14
Lack of nuclear expression of hairy and enhancer of split-1 (HES1) in pancreatic endocrine tumors.
The Notch signaling cascade plays a vital role in the proliferation and differentiation of cells during pancreatic development. Cell line experiments have suggested the involvement of Notch signalingExpand
  • 21
Pancreatic Endocrine Tumors and GIST - Clinical Markers, Epidemiology and Treatment
Expression of the neuroendocrine marker synaptic vesicle protein 2 (SV2) has been reported in a few cases of gastrointestinal stromal tumors (GISTs). The goal of the present study was to assess theExpand
  • 1
Benchmark Comparison of High and Low Performers to Identify Key Success Factors in the care of Type 2 Diabetes in Sweden
Aims: The Swedish National Diabetes Register (NDR) has shown large geographical differences in treatment outcomes for diabetes patients in primary care, both between and within the 21 county councilsExpand
  • 2